These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35527171)

  • 21. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated with Diabetes Control in Predominately African American and Hispanic Population with Newly Diagnosed Type 2 Diabetes.
    Morkos M; Tahsin B; Fogelfeld L
    J Racial Ethn Health Disparities; 2021 Apr; 8(2):332-338. PubMed ID: 32557276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study.
    Gomes MB; Tang F; Chen H; Cid-Ruzafa J; Fenici P; Khunti K; Rathmann W; Shestakova MV; Surmont F; Watada H; Medina J; Shimomura I; Saraiva GL; Cooper A; Nicolucci A
    Front Endocrinol (Lausanne); 2022; 13():831676. PubMed ID: 35527995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in Asian patients with diabetes: The Registry for Assessing OAD Usage in Diabetes Management (REASON) Asia study.
    Vichayanrat A; Matawaran BJ; Wibudi A; Ferdous HS; Aamir AH; Aggarwal SK; Bajpai S
    J Diabetes; 2013 Sep; 5(3):309-18. PubMed ID: 23462227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
    Bae JP; Duan R; Fu H; Hoogwerf BJ
    Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin.
    Raccah D; Chou E; Colagiuri S; Gaàl Z; Lavalle F; Mkrtumyan A; Nikonova E; Tentolouris N; Vidal J; Davies M
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27606888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct associations of self-monitoring of blood glucose with glycemic control and hypoglycemia between groups of recently diagnosed and long-term follow-up type 2 diabetes: The Taiwan Diabetes Registry.
    Wang JS; Lo SH; Yeh YP; Hwu CM; Huang CN; Hsieh CH; Sheu WH
    Int J Clin Pract; 2021 Sep; 75(9):e14410. PubMed ID: 34048138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Search for clinical predictors of good glycemic control in patients starting or intensifying oral hypoglycemic pharmacological therapy: A multicenter prospective cohort study.
    Ren Q; Ji LN; Lu JM; Li YF; Li QM; Lin SS; Lv XF; Wang L; Xu Y; Guo XH; Guo QY; Ma L; Du J; Chen YL; Zhao CL; Zhang QL; She QM; Jiao XM; Lu MH; Sun XM; Gao Y; Zhang J
    J Diabetes Complications; 2020 Feb; 34(2):107464. PubMed ID: 31771933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of diabetes treatment with long-term glycemic patterns in patients with type 2 diabetes mellitus: A prospective cohort study.
    Luo M; Tan CS; Lim WY; Chia KS; Tang WE; Tai ES; Venkataraman K
    Diabetes Metab Res Rev; 2019 May; 35(4):e3122. PubMed ID: 30600922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycemic control in Kuwaiti diabetes patients treated with glucose-lowering medication.
    Abdullah A; Alkandari A; Longenecker JC; Devarajan S; Alkhatib A; Al-Wotayan R; Al-Duwairi Q; Tuomilehto J
    Prim Care Diabetes; 2020 Aug; 14(4):311-316. PubMed ID: 31911041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Potentially Modifiable Diabetes Care Factors With Glycemic Control in Patients With Insulin-Treated Type 2 Diabetes.
    Lauffenburger JC; Lewey J; Jan S; Lee J; Ghazinouri R; Choudhry NK
    JAMA Netw Open; 2020 Jan; 3(1):e1919645. PubMed ID: 31968115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specialist-led diabetes registries and predictors of poor glycemic control in type 2 diabetes: Insights into the functionally refractory patient from the LMC Diabetes Registry database.
    Aronson R; Orzech N; Ye C; Goldenberg R; Brown V
    J Diabetes; 2016 Jan; 8(1):76-85. PubMed ID: 25565383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Bijelic R; Balaban J; Milicevic S; Sipka SU
    Med Arch; 2020 Feb; 74(1):14-18. PubMed ID: 32317828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes.
    Park SD; Kim NY; Jeon JH; Kim JG; Lee IK; Park KG; Choi YK
    Korean J Intern Med; 2021 Jul; 36(4):942-948. PubMed ID: 34092049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Glycemic Control, Lifestyle and Clinical Characteristics in Patients with Type 2 Diabetes Treated at King Abdullah University Hospital in Jordan.
    Al-Eitan LN; Nassar AM; Saadeh NA; Almomani BA
    Can J Diabetes; 2016 Dec; 40(6):496-502. PubMed ID: 27212046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with the degree of glycemic deterioration among patients with type 2 diabetes who dropped out of diabetes care: A longitudinal analysis using medical claims and health checkup data in Japan.
    Ihana-Sugiyama N; Sugiyama T; Imai K; Yanagisawa-Sugita A; Tanaka H; Ohsugi M; Ueki K; Tamiya N; Kobayashi Y
    J Diabetes Investig; 2022 Mar; 13(3):571-579. PubMed ID: 34599560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-sectional and longitudinal relationships of body mass index with glycemic control in children and adolescents with type 1 diabetes mellitus.
    Nansel TR; Lipsky LM; Iannotti RJ
    Diabetes Res Clin Pract; 2013 Apr; 100(1):126-32. PubMed ID: 23339757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study.
    Borgharkar SS; Das SS
    BMJ Open Diabetes Res Care; 2019; 7(1):e000654. PubMed ID: 31413840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.